WO2002053554A3 - Tetraetherlipidderivate und tetraetherlipidderivate enthaltende liposomen und lipidagglomerate sowie deren verwendung - Google Patents

Tetraetherlipidderivate und tetraetherlipidderivate enthaltende liposomen und lipidagglomerate sowie deren verwendung Download PDF

Info

Publication number
WO2002053554A3
WO2002053554A3 PCT/EP2001/015356 EP0115356W WO02053554A3 WO 2002053554 A3 WO2002053554 A3 WO 2002053554A3 EP 0115356 W EP0115356 W EP 0115356W WO 02053554 A3 WO02053554 A3 WO 02053554A3
Authority
WO
WIPO (PCT)
Prior art keywords
lipid
tetraether
derivatives
agglomerates
lipid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/015356
Other languages
English (en)
French (fr)
Other versions
WO2002053554A2 (de
Inventor
Christine Kuehl
Bernhard Tewes
Martin Hagen
Felix Gropp
Ralf Littger
Uwe Marx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bernina Biosystems GmbH
Original Assignee
Bernina Biosystems GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bernina Biosystems GmbH filed Critical Bernina Biosystems GmbH
Priority to EP01985932A priority Critical patent/EP1347964A2/de
Publication of WO2002053554A2 publication Critical patent/WO2002053554A2/de
Publication of WO2002053554A3 publication Critical patent/WO2002053554A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Die Erfindung betrifft neue Tetraeterlipidderivate, die zur Herstellung von einfach und verlälich anwendbaren Liposomen und Lipidagglomeraten mit verbesserter Stabilität verwendet werden können. Die Erfindung betrifft ebenfalls Liposomen und Lipidagglomerate mit einer höheren Lebensdauer in vivo.
PCT/EP2001/015356 2000-12-28 2001-12-28 Tetraetherlipidderivate und tetraetherlipidderivate enthaltende liposomen und lipidagglomerate sowie deren verwendung Ceased WO2002053554A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP01985932A EP1347964A2 (de) 2000-12-28 2001-12-28 Tetraetherlipidderivate und tetraetherlipidderivate enthaltende liposomen und lipidagglomerate sowie deren verwendung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2000165561 DE10065561A1 (de) 2000-12-28 2000-12-28 Tetraetherlipidderivate und Tetraetherlipidderivate enthaltende Liposomen und Lipidagglomerate sowie deren Verwendung
DE10065561.0 2000-12-28

Publications (2)

Publication Number Publication Date
WO2002053554A2 WO2002053554A2 (de) 2002-07-11
WO2002053554A3 true WO2002053554A3 (de) 2002-09-19

Family

ID=7669335

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/015356 Ceased WO2002053554A2 (de) 2000-12-28 2001-12-28 Tetraetherlipidderivate und tetraetherlipidderivate enthaltende liposomen und lipidagglomerate sowie deren verwendung

Country Status (3)

Country Link
EP (1) EP1347964A2 (de)
DE (1) DE10065561A1 (de)
WO (1) WO2002053554A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1509487A1 (de) * 2002-02-01 2005-03-02 Bernina Biosystems GmbH Synthetische tetraether und synthesestrategien dafür
DE10228857B4 (de) * 2002-06-26 2006-11-16 Surface & Interface Technologies Gmbh Rosenhof Tetraetherlipide mit kleinen Kopfgruppen, deren Herstellung und Verwendung
DE10249401A1 (de) * 2002-10-23 2004-05-13 Bernina Biosystems Gmbh Liposomen formende Zusammensetzung
DE102004033667A1 (de) * 2004-07-01 2006-02-02 Institut für Bioprozess- und Analysenmesstechnik e.V. Kompositmaterialien mit Tetraetherlipiden und deren Herstellung
DE102012216378B4 (de) * 2012-09-14 2014-05-15 Institut für Bioprozess- und Analysenmesstechnik e.V. Immobilisierungsmatrix mit Tetraetherlipidschicht, Verfahren zu deren Herstellung und Biosensorchip umfassend diese Immobilisierungsmatrix
EP2711369A1 (de) 2012-09-20 2014-03-26 Bernina Plus GmbH Liposome mit Tetraetherlipidderivaten
KR20260065891A (ko) 2023-09-01 2026-05-11 노보아크 게엠베하 핵산 카고 및 이온화가능한 지질을 갖는 지질 나노입자
CN119909014A (zh) * 2024-12-16 2025-05-02 南方科技大学 一种脂质体及其制备方法、应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008202A1 (en) * 1991-10-23 1993-04-29 National Research Council Of Canada Formation of stable liposomes from lipid extracts of archaeobacteria (archaea)
US5391726A (en) * 1992-04-30 1995-02-21 The Dow Chemical Company Preparation of giant ring compounds
WO1997031927A1 (de) * 1996-02-29 1997-09-04 Freisleben H J Tetraetherlipide und diese enthaltende liposomen sowie deren verwendung
WO1999010337A1 (de) * 1997-08-22 1999-03-04 Bernina Biosystems Gmbh Tetraetherlipidderivate und tetraetherlipidderivate enthaltende liposomen und lipidagglomerate sowie deren verwendung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008202A1 (en) * 1991-10-23 1993-04-29 National Research Council Of Canada Formation of stable liposomes from lipid extracts of archaeobacteria (archaea)
US5391726A (en) * 1992-04-30 1995-02-21 The Dow Chemical Company Preparation of giant ring compounds
WO1997031927A1 (de) * 1996-02-29 1997-09-04 Freisleben H J Tetraetherlipide und diese enthaltende liposomen sowie deren verwendung
WO1999010337A1 (de) * 1997-08-22 1999-03-04 Bernina Biosystems Gmbh Tetraetherlipidderivate und tetraetherlipidderivate enthaltende liposomen und lipidagglomerate sowie deren verwendung

Also Published As

Publication number Publication date
EP1347964A2 (de) 2003-10-01
WO2002053554A2 (de) 2002-07-11
DE10065561A1 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
WO2003041681A3 (en) Lipid carrier compositions with enhanced blood stability
AU2002236666A1 (en) Measuring distances in the eye
AU2001231738A1 (en) Romp with oligomeric uv-absorbers
IL154705A0 (en) Polyarylcarboxamides useful as lipid lowering agents
IL152711A0 (en) Improvements to the fluorescent polymer-qtl approach to biosensing
AU2001247296A1 (en) In vivo production of cyclic peptides
AU2001284362A1 (en) Resorcinol derivatives
AU2001259814A1 (en) Battery manufacture
AU2001232761A1 (en) Fully-locking torque-proportioning differential
AU2002331313A1 (en) Use of l-polynucleotides and derivatives thereof for in vivo imaging
HUP0303838A3 (en) Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
AU2002235780A1 (en) Flavour concentrates
WO2001040177A3 (en) Esters of vitamin d3 and uses thereof
AU1911502A (en) Biphenylcarboxamides useful as lipid lowering agents
AU2001275677A1 (en) 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
AU2001278753A1 (en) Air-hydrogen cell
AU2001280167A1 (en) Novel propenohydroxamic acid derivatives
AU2001267852A1 (en) Novel pyrazinone derivatives
AU2001235437A1 (en) Isothiazolecarboxylic acid derivatives and their use as microbicides
WO2004037223A3 (de) Liposomen formende zusammensetzung
AU2001266290A1 (en) Thermochromic composition
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AU302982S (en) Electric connector
AU2001272909A1 (en) Assessing levels of o6-alkylguanine-dna alkyltransferase in vivo
AUPR968801A0 (en) Improvements in enzyme stability

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001985932

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001985932

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001985932

Country of ref document: EP